Srini Tummala MD FSIR FSVM (@srinitummala) 's Twitter Profile
Srini Tummala MD FSIR FSVM

@srinitummala

Dedicated to CLI. SIR EAC Member & PAD CSC Educ Rep YouTube Dr Tummala’s Vasc Channel Tweets my own; not medical advice

ID: 1918295101

linkhttps://www.youtube.com/@vasculardisease calendar_today29-09-2013 22:12:18

3,3K Tweet

3,3K Takipçi

705 Takip Edilen

CCC Live Cases (@ccclivecases) 's Twitter Profile Photo

We are excited to announce that Dr. Prakash Krishnan and his team at Mount Sinai Fuster Heart Hospital have successfully performed the first procedure in the United States utilizing an innovative drug-eluting below-the-knee resorbable scaffold.

We are excited to announce that <a href="/PK_MountSinai/">Dr. Prakash Krishnan</a> and his team at <a href="/MountSinaiHeart/">Mount Sinai Fuster Heart Hospital</a> have successfully performed the first procedure in the United States utilizing an innovative drug-eluting below-the-knee resorbable scaffold.
NY Endovascular Summit (@endovascularny) 's Twitter Profile Photo

Happy 4th of July! #NYEVS2024 will be here before you know it. Get a head start on your fall planning with 25% off registration for this week only! Register and use code JULY4DEAL here: nyevs.org/registration-i… #PAD #cardiotwitter #endovascular #mountsinai

Happy 4th of July! #NYEVS2024 will be here before you know it. Get a head start on your fall planning with 25% off registration for this week only!

Register and use code JULY4DEAL here: nyevs.org/registration-i…

#PAD #cardiotwitter #endovascular #mountsinai
Srini Tummala MD FSIR FSVM (@srinitummala) 's Twitter Profile Photo

Closure devices vary significantly in challenging antegrade CFA/SFA access with bulky calcified post plaque. Proced successfully completed with direct visual using USN guidance. BLUE Vasorum USA, Inc closure device, RED is plaque. Society of Interventional Radiology American College of Cardiology The VIVA Foundation New Cardiovascular Horizons

Srini Tummala MD FSIR FSVM (@srinitummala) 's Twitter Profile Photo

Great turnout last night for a topic that is not glamorous but so vital for our patients. We have a long way to go in terms of optimizing med management for patients pre and post PAD revascularization. Think personalized thrombophylaxis in the future. TEG is only the start!

Great turnout last night for a topic that is not glamorous but so vital for our patients. We have a long way to go in terms of optimizing med management for patients  pre and post PAD revascularization. Think personalized thrombophylaxis in the future. TEG is only the start!